← Back to all media

Is now the time to buy biotech shares?

Despite the recent dramatic correction in financial markets sparked by the COVID-19 fears and an oil price war, the U.S. equity market has notched up an impressive performance over the past 12 months. The NASDAQ 100 Index rose by 24.0% from 1 March 2019 to 29 February 2020. But the performance of the NASDAQ Biotech Index lagged, increasing by only 7.5% over the same period. That reflects a period of normalisation after a strong performance peaking in 2015.

Published on 11th March 2020



The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.

An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.

The material on this website is intended to be viewed only by persons resident in the UK.

The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.

No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.

The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).

I do not accept →